Atlas Trials

First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma.

Clinical trial NCT01964287 · COMPLETED

Trial details

NCT number
NCT01964287
Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Metastatic Pancreatic Adenocarcinoma
Start date
2013-09-24
Primary completion
2016-12-22
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.